This article is more than 5 years old. Information may no longer be current.

Aloe-vera-derived sugar inhibits corneal scarring after refractive surgery

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

LONDON — A macromolecular sugar derived from aloe vera is a safe, cheap, nontoxic and potentially therapeutic agent for prevention of scarring and haze following corneal refractive surgery, according to one specialist speaking here.

At the meeting of the United Kingdom and Ireland Society of Cataract and Refractive Surgeons, held in conjunction with the European Society of Cataract and Refractive Surgeons meeting here, Romesh Angunawela, MD, spoke about the use of the aloe-vera-derived sugar, mannose-6-phosphate (M6P) in refractive surgery.

"Key to the scarring and haze formation following corneal injury is the transformation of passive keratocytes into fibroblasts and in particular myofibroblasts," said Dr. Angunawela, of St. Thomas's Hospital, London. "This process is typical of the human adult organism, while in the embryo healing occurs without scarring."

The balance between scar-free regenerative healing and healing with scarring hinges on the mix of cytokines released during tissue injury, and in particular on the TGF-beta family of cytokines, he explained. A predominance of TGF-beta 3 during healing in the embryo results in scar-free regenerative healing, while a predominance of TGF-beta 1 and 2 leads to characteristic adult scar formation.

"TGF is an obvious target for the modulation of corneal wound healing," the surgeon said. "The M6P, which binds competitively to the same cell receptor as the TGF-beta family, competitively antagonizes its pro-scarring actions and therefore reduces or stops scarring in the skin."

The effects of M6P were investigated in cultured human corneal cells, exposing them to culture media containing TGF-beta 1 with or without M6P. Cells without TGF-beta and M6P were used as controls.

"M6P proved to significantly inhibit the effect of TGF-beta on corneal keratocytes, suppressing their differentiation to myofibroblasts. The difference between groups was statistically significant," Dr. Angunawela concluded.